Publication: Adipose-derived stem cells weigh in as novel therapeutics for acute lung injury
Open/View Files
Date
2013
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Gupta, Kushagra, Anja Hergrueter, and Caroline A Owen. 2013. “Adipose-derived stem cells weigh in as novel therapeutics for acute lung injury.” Stem Cell Research & Therapy 4 (1): 19. doi:10.1186/scrt167. http://dx.doi.org/10.1186/scrt167.
Research Data
Abstract
Acute lung injury is characterized by intense neutrophilic lung inflammation and increased alveolar-capillary barrier permeability leading to severe hypoxemia, and is associated with high mortality despite improvements in supportive care. There is an urgent need for effective therapies for acute lung injury. Zhang and colleagues tested the efficacy of adipose-derived stem cells in acute lung injury in mice. When adipose-derived stem cells were delivered to mice that had been challenged with lipopolysaccharide, they potently limited acute lung inflammation and injury in the mice, indicating that adipose-derived stem cells have therapeutic potential in acute lung injury in humans. Herein, we discuss the advantages and potential limitations of using adipose-derived stem cells as therapeutics for human acute lung injury.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service